Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$22,907,544
+$3,565,289 QoQ
Shares Held
91,033
+2.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#567
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Dec 31, 2021CallValue
$135,400
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $235,547,820 across 12 Drug Manufacturers - General names. ABBV ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,395 | $78,436,731 | |
| 2 | JNJ |
Johnson & Johnson
|
184,287 | $46,803,369 | |
| 3 | AMGN |
Amgen Inc
|
97,295 | $35,232,465 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
91,033 | $22,907,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
144,784 | $18,292,010 | |
| 6 | MRK |
Merck & Co., Inc.
|
130,290 | $16,742,265 | |
| 7 | PFE |
Pfizer Inc
|
272,912 | $6,571,720 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,227 | $5,429,359 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,907,544 | 91,033 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $19,342,255 | 88,934 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $20,887,184 | 91,414 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $22,624,468 | 97,713 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $14,406,525 | 77,613 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $16,775,428 | 80,066 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $15,060,430 | 84,752 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $17,357,307 | 87,894 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $15,126,005 | 88,188 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $15,116,667 | 83,013 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $12,398,684 | 80,007 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $11,398,767 | 76,471 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $13,019,633 | 96,635 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $14,106,794 | 88,516 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $13,188,668 | 81,608 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $12,414,693 | 92,502 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $16,534,847 | 107,958 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $15,496,094 | 95,590 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $135,400 | 1,000 | Call | Sole | 2022-01-11 | |
| 2021-12-31 | $17,160,731 | 126,741 | Shares | Sole | 2022-01-11 | |
| 2021-09-30 | $13,829,689 | 128,207 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $11,891,742 | 105,573 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $7,086,570 | 65,483 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $7,483,034 | 69,837 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $5,715,510 | 65,253 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $4,528,356 | 46,123 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $4,486,524 | 58,886 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||